Purchases and Sales Made in Q2 2024 in Century Therapeutics, Inc. (IPSC)
This table provides information about the institutional ownership of Century Therapeutics, Inc. (IPSC) during Q2 2024. The information is specifically focused on institutions that hold shares of Century Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-14.6K- 50.92% |
$36K - $59.2K
|
14.1K
$7.33K
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-42.4K- 15.65% |
$104K - $172K
|
229K
$119K
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-51.7K- 72.03% |
$127K - $209K
|
20.1K
$10.4K
|
|
|
Jun 12, 2025
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-88.9K- 92.45% |
$219K - $360K
|
7.26K
$3.78K
|
|
|
Aug 14, 2024
Q2 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-283K- 96.4% |
$697K - $1.15M
|
10.6K
$5.5K
|
|
|
Aug 08, 2024
Q2 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-339K- 55.11% |
$834K - $1.37M
|
276K
$144K
|